EvoEndo

EvoEndo is a Health Care startup founded in 2017 in the United States. The company's slogan "Evolving Unsedated Endoscopy" encapsulates its mission to provide an innovative solution in the medical field. EvoEndo’s Single-Use Endoscopy System offers a non-invasive alternative for patients aged five and above to undergo a transnasal EGD exam without the need for anesthesia or sedation.

The startup's proprietary technology includes an ultra-slim gastroscope and a virtual reality patient distraction system, aimed at enhancing the patient experience. Furthermore, EvoEndo provides a comprehensive training program, specifically tailored to assist physicians and hospitals in initiating and expanding a TNE (Transnasal Endoscopy) program within their practice. This initiative not only offers patients and their families an unsedated alternative to upper endoscopy but also equips medical professionals and facilities with the necessary resources to deliver quality care.

As of 13 April 2023, EvoEndo secured a Venture Round investment from the GI Opportunity Fund 1. This financial support signifies a vote of confidence from an established investor and underscores the potential and relevance of EvoEndo’s innovative approach within the healthcare industry.